Bring Health to Your Portfolio With Pharma ETFs

The video discusses various ways investors can engage with the healthcare sector through ETFs, focusing on XLV and its performance. It highlights the pharmaceutical ETF PJP, which includes biotech, and contrasts it with more traditional ETFs. The discussion also covers the growth and value aspects of pharma investments, driven by demographic trends like aging baby boomers. Finally, it examines the global exposure of the Van Eck Vectors Generic Drugs ETF, which includes international markets, and the associated risks and benefits.

What is the significance of the PJP PowerShares Dynamic Pharmaceuticals ETF in the context of biotech?

How does the Van Eck Vectors Generic Drugs ETF differ from other pharmaceutical ETFs mentioned?